Literature DB >> 12061943

Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.

Noah Lechtzin1, Jeffery Rothstein, Lora Clawson, Gregory B Diette, Charles M Wiener.   

Abstract

Patients with amyotrophic lateral sclerosis (ALS) invariably develop respiratory muscle weakness and most die from pulmonary complications. There are numerous tests available to evaluate respiratory status in ALS and it is important to understand their various advantages and limitations. Forced vital capacity (FVC) is commonly used but can remain normal despite substantial inspiratory muscle weakness. Maximal pressures measured at the mouth are useful for excluding weakness if they are normal but are difficult to interpret if abnormal. Invasive testing, such as measurement of transdiaphragmatic pressure, provides an accurate measure of inspiratory strength but is not readily available and is not practical for serial measures. There are supportive respiratory techniques that have been shown to benefit patients with ALS. Clinicians should be familiar with these interventions, including mechanically assisted coughing, non-invasive ventilation and tracheostomy with mechanical ventilation. Observational studies have demonstrated improved survival and quality of life with noninvasive ventilation. Tracheostomy with long-term mechanical ventilation is not frequently used but can be an important component of care for ALS. This review describes an approach to respiratory evaluation and care of patients with ALS.

Entities:  

Mesh:

Year:  2002        PMID: 12061943     DOI: 10.1080/146608202317576480

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  14 in total

1.  Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats.

Authors:  N L Nichols; R A Johnson; I Satriotomo; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2014-03-28       Impact factor: 1.931

2.  Mechanisms of Enhanced Phrenic Long-Term Facilitation in SOD1G93A Rats.

Authors:  Nicole L Nichols; Irawan Satriotomo; Latoya L Allen; Ashley M Grebe; Gordon S Mitchell
Journal:  J Neurosci       Date:  2017-05-12       Impact factor: 6.167

3.  Phrenic long-term facilitation following intrapleural CTB-SAP-induced respiratory motor neuron death.

Authors:  Nicole L Nichols; Taylor A Craig; Miles A Tanner
Journal:  Respir Physiol Neurobiol       Date:  2017-08-16       Impact factor: 1.931

4.  5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1G93A).

Authors:  Lauren F Borkowski; Taylor A Craig; Olivia E Stricklin; Katherine A Johnson; Nicole L Nichols
Journal:  Respir Physiol Neurobiol       Date:  2020-06-03       Impact factor: 1.931

Review 5.  Therapeutic potential of intermittent hypoxia: a matter of dose.

Authors:  Angela Navarrete-Opazo; Gordon S Mitchell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-17       Impact factor: 3.619

6.  Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis.

Authors:  Nicole L Nichols; Genevieve Gowing; Irawan Satriotomo; Lisa J Nashold; Erica A Dale; Masatoshi Suzuki; Pablo Avalos; Patrick L Mulcrone; Jacalyn McHugh; Clive N Svendsen; Gordon S Mitchell
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

7.  Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.

Authors:  Nicole L Nichols; Irawan Satriotomo; Daniel J Harrigan; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2015-08-16       Impact factor: 5.330

Review 8.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

Review 9.  Ventilatory control in ALS.

Authors:  Nicole L Nichols; J Van Dyke; L Nashold; I Satriotomo; M Suzuki; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-18       Impact factor: 1.931

10.  Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Dan Krakora; Corey Macrander; Masatoshi Suzuki
Journal:  Neurol Res Int       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.